ArticleEcotoxicology and environmental safety2026
Developmental perfluorooctane sulfonate (PFOS) exposure alters gene expression in nucleus accumbens and prefrontal cortex and impairs cognition in rats: A transcriptomic and mediation analysis.
Article in Ecotoxicology and environmental safety, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
Growing evidence suggests that developmental exposure to perfluorooctanesulfonic acid (PFOS) is linked to neurobehavioral outcomes. Pregnant female rats were exposed to PFOS (15 mg/L) or Tween vehicle through drinking water until the offspring were weaned at three weeks of age. As adults, cognitive flexibility and impulsive decision-making were assessed in 8 PFOS-exposed and 8 vehicle-exposed rats using extradimensional set-shifting and delay discounting tasks, respectively. Cognitive flexibility was measured by the number of trials required to reach the criterion, while impulsive decision-making was quantified as the area under the curve (AUC) of the percent preference for the large reward lever (% CHL), response omissions (% omit), and response latency (in second) at delays of 0, 15, 30, and 45 s. Brain tissues from the nucleus accumbens, prefrontal cortex, and hippocampus were extracted for bulk RNA sequencing. Differential gene expression analysis and gene set enrichment analysis were performed. Mediation analysis was performed to assess the mediated effect of DEGs in the associations between PFOS and neurobehavioral tests. We identified 62 differentially expressed genes (DEGs) in the nucleus accumbens, 34 in the hippocampus, and 59 in prefrontal cortex tissues due to PFOS exposure. We also found DEGs, including NAT8F2, AC080157.1, ABCG3, and ENSRNOG00000063145 mediated between PFOS and neurobehavioral assessments. Pathways that were associated with both PFOS exposure and neurobehavioral outcomes (% CHL and % omit) included extracellular matrix-receptor interaction, focal adhesion, and glutathione metabolism in the nucleus accumbens. Developmental PFOS exposure may alter gene expression in the nucleus accumbens and prefrontal cortex and was associated with impaired cognitive flexibility and impulsive decision-making. These exploratory findings highlight potential pathways, including ECM-receptor interaction and glutathione metabolism, that warrant further validation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.